Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-545.55%
operating margin TTM
-607.88%
revenue TTM
4.98 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.80 |
| peg ratio | -0.04 |
| price to book ratio | 6.02 |
| price to sales ratio | 16.99 |
| enterprise value multiple | -2.99 |
| price fair value | 6.02 |
profitability ratios | |
|---|---|
| gross profit margin | 95.91% |
| operating profit margin | -607.88% |
| pretax profit margin | -588.39% |
| net profit margin | -545.55% |
| return on assets | -247.44% |
| return on equity | -241.82% |
| return on capital employed | -371.43% |
liquidity ratio | |
|---|---|
| current ratio | 3.84 |
| quick ratio | 3.84 |
| cash ratio | 1.67 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 429.20 |
| days of payables outstanding | 3,821.56 |
| cash conversion cycle | -3,392.36 |
| receivables turnover | 0.85 |
| payables turnover | 0.10 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -155.63 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.00 |
| cash per share | 0.00 |
| operating cash flow per share | -0.00 |
| free cash flow operating cash flow ratio | 1.16 |
| cash flow coverage ratios | -155.63 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -59,246.42 |
Frequently Asked Questions
When was the last time Alterity Therapeutics Limited (NASDAQ:ATHE) reported earnings?
Alterity Therapeutics Limited (ATHE) published its most recent earnings results on 31-12-2024.
What is Alterity Therapeutics Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Alterity Therapeutics Limited (NASDAQ:ATHE)'s trailing twelve months ROE is -241.82%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Alterity Therapeutics Limited (ATHE) currently has a ROA of -247.44%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ATHE's net profit margin stand at?
ATHE reported a profit margin of -545.55% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ATHE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.84 in the most recent quarter. The quick ratio stood at 3.84, with a Debt/Eq ratio of 0.01.